PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R102. A total of 36 filers reported holding PLURISTEM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $21,000 | -36.4% | 33,794 | 0.0% | 0.00% | -50.0% |
Q1 2019 | $33,000 | -8.3% | 33,794 | -26.5% | 0.00% | 0.0% |
Q4 2018 | $36,000 | -66.4% | 46,000 | -43.9% | 0.00% | -60.0% |
Q3 2018 | $107,000 | -8.5% | 81,998 | -14.6% | 0.01% | -16.7% |
Q2 2018 | $117,000 | +34.5% | 96,000 | +50.7% | 0.01% | +20.0% |
Q1 2018 | $87,000 | -1.1% | 63,700 | 0.0% | 0.01% | -16.7% |
Q4 2017 | $88,000 | -43.9% | 63,700 | -38.6% | 0.01% | -53.8% |
Q3 2017 | $157,000 | +33.1% | 103,700 | +12.7% | 0.01% | +30.0% |
Q2 2017 | $118,000 | -12.6% | 92,000 | 0.0% | 0.01% | -16.7% |
Q1 2017 | $135,000 | +50.0% | 92,000 | +46.0% | 0.01% | -7.7% |
Q4 2016 | $90,000 | -10.9% | 63,000 | 0.0% | 0.01% | -7.1% |
Q3 2016 | $101,000 | +1022.2% | 63,000 | +800.0% | 0.01% | +1300.0% |
Q2 2016 | $9,000 | -18.2% | 7,000 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $11,000 | +37.5% | 7,000 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $8,000 | – | 7,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARK Investment Management | 3,793,249 | $3,679,000 | 0.10% |
Nikko Asset Management Americas, Inc. | 928,240 | $900,000 | 0.02% |
ETF MANAGERS GROUP, LLC | 243,009 | $233,000 | 0.01% |
Virtu Financial LLC | 85,104 | $83,000 | 0.01% |
Psagot Value Holdings Ltd. | 127,215 | $123,000 | 0.01% |
HERITAGE INVESTORS MANAGEMENT CORP | 74,878 | $73,000 | 0.00% |
Harel Insurance Investments & Financial Services Ltd. | 33,794 | $33,000 | 0.00% |
Certified Advisory Corp | 5,000 | $5,000 | 0.00% |
Sumitomo Mitsui Trust Holdings, Inc. | 908,095 | $881,000 | 0.00% |
Renaissance Technologies | 1,580,610 | $1,533,000 | 0.00% |